Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.
Advertisement
A team of UCLA researchers said they have figured out why ovarian cancer comes back after treatment with the chemotherapy drug carboplatin. The researchers discovered that some of the tumor cells that don’t produce the protein CA125, have a strong ability to repair their DNA and resist programmed cell death. This allows the cells to ...click here to read more
Physicians at Princeton University are urging a global fund to manage the costs of developing new vaccines and defusing crises that arise every time there is a new epidemic. The writers said the recent Ebola epidemic is a case in point. In spite of the fact that Ebola is a preventable disease, an effective vaccine ...click here to read more
In what the World Health Organization (WHO) sees as an extremely promising development, an interim analysis of the Guinea Phase III efficacy vaccine trial shows that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. Preliminary results of these analyses are published in The Lancet. Though the vaccine has shown 100% efficacy in individuals ...click here to read more
Advertisement
Recent research from the National Institute of Nursing Research (NINR), a component of the National Institutes of Health (NIH) shows that a protein that was, until recently, linked only to acute symptoms following a traumatic brain injury (TBI), may also be responsible for long-term and chronic complications following brain injuries. The details of the study are ...click here to read more
Clinicians need to take into account the risk of harmful weight loss in adults who are prescribed common medications for dementia. According to researchers and clinicians at the University of California, San Francisco, a certain class of drugs (cholinesterase inhibitors) used in the treatment of dementia can result in clinically significant weight loss. Their study ...click here to read more
The FDA recently approved a new device to treat obesity without invasive surgery. The device, called ReShape Integrated Dual Balloon System or ReShape Dual Balloon for short, is designed to help adult patients lose weight. The primary modus-operandi of the device seems to be to take up space in the stomach, and trigger a feeling ...click here to read more
New research points to a drug used to treat advanced skin cancer as an effective means to treat medulloblastoma, a type of brain cancer, in adults. The research was published online in the Journal of Clinical Oncology, and was led by the St. Jude Children’s Research Hospital. Medulloblastoma develops in the cerebellum at the base ...click here to read more
One in every 5 adults has some form of disability or the other according to a recent study published by the Centers for Disease Control and Prevention. The most common form of disability type was a mobility limitation – characterized by serious difficulty in walking or climbing stairs. This form of disability is reported by one ...click here to read more
Advertisement
Five-Star Guarantee of Satisfaction
